Home › Therapeutic areas › Hematology › AL Amyloidosis

AL Amyloidosis (4 companies)

Companies with an active program in AL Amyloidosis.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
AUTL Autolus Therapeutics HematologyImmunology+3 Rare 1 Approved $290M 12
FBIO Fortress Biotech DermatologyHematology+4 Rare 1 Approved $61.4M 16
IMMX Immix Biopharma Hematology Rare 1 Phase 1 $603M 1
IONS Ionis Pharmaceuticals CardiovascularHematology+5 Rare 2 Approved $4.49B 29